• Featured Product
  • KD/KO Validated

ORC6 Polyclonal antibody

ORC6 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, ELISA

Conjugate

Unconjugated

Cat no : 17784-1-AP

Synonyms

ORC6, ORC6L


☆大好評トライアルサイズ ¥20,000~! >>> 一次抗体特別価格キャンペーン開催中!


Tested Applications

Positive WB detected inJurkat cells, MCF-7 cells, mouse spleen tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

17784-1-AP targets ORC6 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen ORC6 fusion protein Ag11769 相同性解析による交差性が予測される生物種
Full Name origin recognition complex, subunit 6 like (yeast)
Calculated molecular weight 252 aa, 28 kDa
Observed molecular weight 28 kDa
GenBank accession numberBC063565
Gene symbol ORC6
Gene ID (NCBI) 23594
RRIDAB_2283320
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Protocols

Product Specific Protocols
WB protocol for ORC6 antibody 17784-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Front Immunol

Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression

Authors - Jinfeng Zhu
  • KD Validated
humanWB,IHC

Aging (Albany NY)

Development and validation of a novel prognostic signature in gastric adenocarcinoma.

Authors - Rui Mao
humanWB

Oncotarget

The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis.

Authors - Lifei Fan